Citadel Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-15,600
| Closed | -$1.45M | – | 15210 |
|
|
2021
Q4 | $1.45M | Sell |
15,600
-17,400
| -53% | -$1.15M | ﹤0.01% | 6968 |
|
|
2021
Q3 | $1.97M | Buy |
33,000
+7,800
| +31% | +$461K | ﹤0.01% | 6389 |
|
|
2021
Q2 | $1.72M | Sell |
25,200
-17,500
| -41% | -$1.14M | ﹤0.01% | 6973 |
|
|
2021
Q1 | $2.96M | Sell |
42,700
-7,200
| -14% | -$554K | ﹤0.01% | 5476 |
|
|
2020
Q4 | $3.83M | Buy |
49,900
+30,200
| +153% | +$2.26M | ﹤0.01% | 4151 |
|
|
2020
Q3 | $1.47M | Sell |
19,700
-5,200
| -21% | -$347K | ﹤0.01% | 5306 |
|
|
2020
Q2 | $1.57M | Buy |
24,900
+5,000
| +25% | +$275K | ﹤0.01% | 4990 |
|
|
2020
Q1 | $836K | Sell |
19,900
-34,500
| -63% | -$1.58M | ﹤0.01% | 5644 |
|
|
2019
Q4 | $2.47M | Buy |
54,400
+15,800
| +41% | +$747K | ﹤0.01% | 4077 |
|
|
2019
Q3 | $1.77M | Buy |
38,600
+4,500
| +13% | +$253K | ﹤0.01% | 4679 |
|
|
2019
Q2 | $2M | Buy |
34,100
+1,300
| +4% | +$67.2K | ﹤0.01% | 4510 |
|
|
2019
Q1 | $1.47M | Sell |
32,800
-47,400
| -59% | -$2.17M | ﹤0.01% | 4948 |
|
|
2018
Q4 | $3.12M | Buy |
80,200
+28,600
| +55% | +$1.12M | ﹤0.01% | 3456 |
|
|
2018
Q3 | $2.38M | Sell |
51,600
-28,000
| -35% | -$1.13M | ﹤0.01% | 4121 |
|
|
2018
Q2 | $3.47M | Sell |
79,600
-6,800
| -8% | -$292K | ﹤0.01% | 3280 |
|
|
2018
Q1 | $3.41M | Buy |
86,400
+61,500
| +247% | +$2.39M | ﹤0.01% | 2962 |
|
|
2017
Q4 | $846K | Buy |
24,900
+11,300
| +83% | +$322K | ﹤0.01% | 4895 |
|
|
2017
Q3 | $347K | Sell |
13,600
-3,400
| -20% | -$78K | ﹤0.01% | 5850 |
|
|
2017
Q2 | $287K | Buy |
17,000
+13,610
| +401% | +$187K | ﹤0.01% | 5976 |
|
|
2017
Q1 | $49K | Sell |
3,390
-80
| -2% | -$1.19K | ﹤0.01% | 7046 |
|
|
2016
Q4 | $49K | Buy |
+3,470
| New | +$53.7K | ﹤0.01% | 6876 |
|
|
2016
Q1 | – | Sell |
-2,620
| Closed | -$50K | – | 8389 |
|
|
2015
Q4 | $50K | Sell |
2,620
-2,360
| -47% | -$48.1K | ﹤0.01% | 7320 |
|
|
2015
Q3 | $95K | Buy |
4,980
+2,110
| +74% | +$71.7K | ﹤0.01% | 7006 |
|
|
2015
Q2 | $133K | Sell |
2,870
-8,340
| -74% | -$362K | ﹤0.01% | 6789 |
|
|
2015
Q1 | $490K | Sell |
11,210
-1,660
| -13% | -$77.1K | ﹤0.01% | 4943 |
|
|
2014
Q4 | $447K | Sell |
12,870
-5,010
| -28% | -$203K | ﹤0.01% | 4883 |
|
|
2014
Q3 | $749K | Buy |
17,880
+2,400
| +16% | +$107K | ﹤0.01% | 4083 |
|
|
2014
Q2 | $907K | Buy |
15,480
+100
| +0.7% | +$6.3K | ﹤0.01% | 3629 |
|
|
2014
Q1 | $969K | Sell |
15,380
-9,790
| -39% | -$650K | ﹤0.01% | 3464 |
|
|
2013
Q4 | $1.47M | Sell |
25,170
-9,430
| -27% | -$493K | ﹤0.01% | 2838 |
|
|
2013
Q3 | $1.82M | Buy |
34,600
+1,530
| +5% | +$103K | ﹤0.01% | 2494 |
|
|
2013
Q2 | $2.55M | Buy |
+33,070
| New | +$2.7M | ﹤0.01% | 2245 |
|
Citadel Advisors's ARNA Position: Q1 2022 in Review
Citadel Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 337,629 shares — an estimated $31.4M sold.
Citadel Advisors first reported a position in ARNA in Q2 2013 and held it in 32 quarters. The position peaked at $63.6M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Citadel Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Citadel Advisors sold 337,629 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $31.4M.
- Citadel Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 32 quarters.
- Citadel Advisors's Arena Pharmaceuticals Inc position peaked at $63.6M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.